Syra Health Corp Stock Performance
| SYRA Stock | USD 0.10 0.01 9.09% |
Syra Health holds a performance score of 7 on a scale of zero to a hundred. The entity has a beta of -4.12, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Syra Health are expected to decrease by larger amounts. On the other hand, during market turmoil, Syra Health is expected to outperform it. Use Syra Health Corp value at risk and the relationship between the expected short fall and period momentum indicator , to analyze future returns on Syra Health Corp.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Syra Health Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Syra Health sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Disposition of tradable shares by Deepika Vuppalanchi of Syra Health subject to Rule 16b-3 | 10/23/2025 |
2 | Syra Health Announces Third Quarter Financial Results Margins, Profitability Metrics Improve | 11/12/2025 |
3 | Syra Health amends certificate to revise Class B stock conversion rules By Investing.com - Investing.com South Africa | 11/18/2025 |
4 | Acquisition by Reddy Avutu of 15442 shares of Syra Health at 0.3683 subject to Rule 16b-3 | 11/21/2025 |
5 | Syra Health appoints Gregory Alexander as CEO to drive growth By Investing.com - Investing.com Nigeria | 12/18/2025 |
| Begin Period Cash Flow | 3.3 M | |
| Total Cashflows From Investing Activities | -11.1 K |
Syra Health Relative Risk vs. Return Landscape
If you would invest 8.00 in Syra Health Corp on October 1, 2025 and sell it today you would earn a total of 2.00 from holding Syra Health Corp or generate 25.0% return on investment over 90 days. Syra Health Corp is currently generating 1.0574% in daily expected returns and assumes 11.9936% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Syra, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Syra Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Syra Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Syra Health Corp, and traders can use it to determine the average amount a Syra Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0882
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SYRA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Syra Health is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Syra Health by adding it to a well-diversified portfolio.
Syra Health Fundamentals Growth
Syra Stock prices reflect investors' perceptions of the future prospects and financial health of Syra Health, and Syra Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Syra Stock performance.
| Return On Equity | -0.46 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.17) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | (550.28 K) | ||||
| Shares Outstanding | 11.34 M | ||||
| Price To Book | 0.54 X | ||||
| Price To Sales | 0.16 X | ||||
| Revenue | 7.98 M | ||||
| Gross Profit | 2.23 M | ||||
| EBITDA | (3.68 M) | ||||
| Net Income | (3.76 M) | ||||
| Total Debt | 452.08 K | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (2.93 M) | ||||
| Earnings Per Share | (0.08) X | ||||
| Market Capitalization | 1.19 M | ||||
| Total Asset | 3.68 M | ||||
| Retained Earnings | (8.82 M) | ||||
| Working Capital | 2.74 M | ||||
About Syra Health Performance
By analyzing Syra Health's fundamental ratios, stakeholders can gain valuable insights into Syra Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Syra Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Syra Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 3.40 | 3.02 | |
| Return On Tangible Assets | (1.02) | (1.07) | |
| Return On Capital Employed | (1.23) | (1.29) | |
| Return On Assets | (1.02) | (1.07) | |
| Return On Equity | (1.31) | (1.37) |
Things to note about Syra Health Corp performance evaluation
Checking the ongoing alerts about Syra Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Syra Health Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Syra Health Corp is way too risky over 90 days horizon | |
| Syra Health Corp has some characteristics of a very speculative penny stock | |
| Syra Health Corp appears to be risky and price may revert if volatility continues | |
| Syra Health Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 7.98 M. Net Loss for the year was (3.76 M) with profit before overhead, payroll, taxes, and interest of 2.23 M. | |
| Syra Health generates negative cash flow from operations | |
| About 34.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from benzinga.com: 12 Health Care Stocks Moving In Fridays Pre-Market Session |
- Analyzing Syra Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Syra Health's stock is overvalued or undervalued compared to its peers.
- Examining Syra Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Syra Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Syra Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Syra Health's stock. These opinions can provide insight into Syra Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Syra Stock analysis
When running Syra Health's price analysis, check to measure Syra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syra Health is operating at the current time. Most of Syra Health's value examination focuses on studying past and present price action to predict the probability of Syra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syra Health's price. Additionally, you may evaluate how the addition of Syra Health to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |